Why consider Immune Checkpoint inhibitor Biomarkers, before considering Immunotherapy a mode for treatment

Immunotherapy as a cancer therapy is approved and being implicated for patient treatment, since ipilimumab break into the treatment landscape in 2011. After which tremendous advancement was made in the field of immunotherapy, and in 2016 it is named as American Society of Clinical Oncology’s top cancer therapy (Dizon DS, Krilov L, 2016). Although the […]